Domov › Rak jajčnikov › Pennsylvania › Philadelphia

Klinične študije za Rak jajčnikov v Philadelphia, PA

44 študij za Rak jajčnikov išče udeležence na lokacijah v Philadelphia in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Vključevanje udeležencevFaza 2/3

Thomas Jefferson University Hospital, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Vključevanje udeležencevFaza 2

Pennsylvania Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Fox Chase Cancer Center, Philadelphia
in še 4

Vse starosti · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Vključevanje udeležencevFaza 1/2

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Vključevanje udeležencevFaza 1

Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia

Starost 19 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06586957

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Vključevanje udeležencev

University of Pennsylvania, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05287451

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Vključevanje udeležencevFaza 2

University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Vključevanje udeležencevFaza 2

Site 0232 - University of Pennsylvania, Philadelphia
Site 0178 - Thomas Jefferson University, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05128825

Study of AVZO-021 in Patients With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2

Avenzo Therapeutics Recruiting Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05867251

DESTINY-PANTUMOUR04

Vključevanje udeležencevOpazovalna študija

Research Site, Philadelphia

Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Vključevanje udeležencevFaza 1/2

Perelman School of Medicine at the University of Pennsylvania, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Vključevanje udeležencevFaza 3

University of Pennsylvania Hospital, Philadelphia
Jefferson Health Honickman Center, Philadelphia
Asplundh Cancer Pavilion, Willow Grove · 13 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Vključevanje udeležencevFaza 1

University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213791

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

Vključevanje udeležencevFaza 2

Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 22. sep. 2026 · NCT07059845

Prehabilitation in High-risk Oncologic Surgery

Vključevanje udeležencev

Fox Chase Cancer Center - Philadelphia, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07638410

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Vključevanje udeležencevFaza 1/2

University of Pennsylvania, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT04752826

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Vključevanje udeležencevFaza 3

Hospital of the University of Pennsylvania ( Site 0071), Philadelphia

Starost 18 in več · Ženske · Posodobljeno 17. sep. 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Vključevanje udeležencevFaza 3

Lankenau Medical Center, Wynnewood · 7 mi stran

Starost 18 in več · Ženske · Posodobljeno 15. sep. 2026 · NCT07214779

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Vključevanje udeležencevOpazovalna študija

University of Pennsylvania, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07216105

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Vključevanje udeležencevFaza 1/2

Children's Hospital of Philadelphia, Philadelphia

12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06774963

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Vključevanje udeležencevFaza 1

SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07470853

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Vključevanje udeležencevFaza 1

Normunity Investigational Site, Philadelphia
Normunity Investigational Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07182149

The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry

Vključevanje udeležencevOpazovalna študija

ACPMP, Springfield · 8 mi stran

Vse starosti · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07769346

A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Vključevanje udeležencevFaza 3

Site 0109, Philadelphia
Site 0113, Philadelphia
Site 0114, Willow Grove · 13 mi stran

Starost 18 in več · Ženske · Posodobljeno 12. avg. 2026 · NCT07546500

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Vključevanje udeležencev

University of Pennsylvania/Abramson Cancer Center, Philadelphia
Fox Chase Cancer Center, Philadelphia
Lankenau Medical Center, Wynnewood · 7 mi stran
in še 5

Starost 35–50 · Ženske · Posodobljeno 7. avg. 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Vključevanje udeležencevFaza 3

University of Pennsylvania/Abramson Cancer Center, Philadelphia
Pennsylvania Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
in še 5

Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2

University of Pennsylvania / Abramson Cancer Center, Philadelphia
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT04657068